$270 Million Drug Deal

SAN FRANCISCO — A federal judge preliminarily approved a $270 million antitrust settlement Tuesday against Endo Pharmaceuticals, Teikoku Pharma and Actavis fka Watson Pharmaceuticals for colluding to prevent a generic form of the Lidoderm pain patch from reaching the market.

%d bloggers like this: